BÁO CÁO Y HỌC: " AIDS PATIENTS HAVE INCREASED SURFACTANT PROTEIN D BUT NORMAL MANNOSE BINDING LECTIN LEVELS IN LUNG FLUID" PPT
Tìm thấy 10,000 tài liệu liên quan tới tiêu đề "BÁO CÁO Y HỌC: " AIDS PATIENTS HAVE INCREASED SURFACTANT PROTEIN D BUT NORMAL MANNOSE BINDING LECTIN...":
1 4 1. Department of Hospital Pharmacy, School of Medicine, Kobe University, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan 2. Clinical Pathology and Immunology, Department of Biomedical Informatics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan 3.[r]
association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. 10. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in pa[r]
Corresponding address: Jin Zhong Li, D.V.M. Ph.D., Department of Neurological Surgery, University of Virginia Health System, P. O. Box 800212, Charlottesville, Virginia 22908, USA Received: 2006.05.02; Accepted: 2006.05.31; Published: 2006.06.01 Osteogenic potentials of some recombinan[r]
association between maternal use of loratadine in early pregnancy and birth of infants with hypospadias was the result of multiple testing. Acknowledgments The study was supported by a grant from K A Wallenberg Foundation, Sweden, to BK. Conflict of interest The authors have declared that no conflic[r]
genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther. 2005; 22: 1033-40. 25. Sapone A, Vaira D, Trespidi S, et al. The clinical role of cytochrome P450 genotypes in Helicobacter pylori managem[r]
as both BRCA1-/- and BRCA1+/+ cells showed about a 30-40% reduction in growth. (D) Clonogenic assay. MCF-7, MDA-MB-231 and HCC1937 cells were treated and exposed to AG14361 continuously for 10 days. 5. PARP inhibition remains promising in chemoprevention and therapeutic treatment for BRCA re[r]
As there are only a few longitudinal studies concerning women’s health problems in this field and epidemiological studies of lung function impairment in women and risk factors in a long-[r]
20. Hwang SJ, Luo JC, Chu CW, et al. Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation. J Gastroenterol Hepatol 2001;16:190-5. 21. Lonardo A, Adinolfi LE, Loria P, et al. Steatopsis and hepatitis C virus: Mechanisms and significance for hepatic and extrahe[r]
BAG-1 1 + 0/+ Bcl-2 1 - 1.91 Fold change means a semiquantitative value that represents the general trend of protein changes for the experimental sample to control detected by using the Odyssey Infrared Imaging System. (+) means an increase of signal intensity, and (-) means a decrease of signal int[r]
4. Hadziyannis SJ, Sette HJr., Morgan TR, Balan V, Diago M, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-55. 5. Muir AJ, Bornstein JD and Killenberg PG. Peginterferon[r]
Miles Laboratories, Elkhart, IN), and frozen in isopentane cooled in liquid nitrogen. Transverse sections (10µm) were cut using a Leica CM1850-Cryostat (Leica Microsystem, Nussloch, Germany). Staining for myofibrillar adenosine triphosphatase (mATPase) was done at pH 4.3 [28]. Type I and II muscle f[r]
recipients. Clinical Gastroenterol Hepatol. 2005; 10:S125-31 19. Lee W, Dieterich D. Challenges in the management of HIV and hepatitis C virus infection. Drugs. 2004;64(7):693-700 20. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with Human[r]
18. Farci P, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med, 1996. 335(9): 631-4. 19. Vogt M, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med, 1999.[r]
4. Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Poupon RE, et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435-1440. 5. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihara A, Kiyosawa[r]